Wealthspire Advisors (Maryland)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,198
Closed -$108K 842
2019
Q1
$108K Buy
1,198
+827
+223% +$71.7K 0.01% 614
2018
Q4
$31K Buy
371
+100
+37% +$9.38K ﹤0.01% 1037
2018
Q3
$29K Buy
271
+3
+1% +$329 ﹤0.01% 1166
2018
Q2
$29K Sell
268
-28
-9% -$2.92K ﹤0.01% 1169
2018
Q1
$30K Buy
296
+14
+5% +$1.43K ﹤0.01% 1162
2017
Q4
$28K Sell
282
-100
-26% -$9.48K ﹤0.01% 1218
2017
Q3
$36K Buy
382
+48
+14% +$5.1K ﹤0.01% 1095
2017
Q2
$37K Sell
334
-48
-13% -$5.08K ﹤0.01% 1048
2017
Q1
$38K Buy
382
+62
+19% +$5.91K 0.01% 875
2016
Q4
$29K Sell
320
-3
-0.9% -$259 ﹤0.01% 915
2016
Q3
$27K Sell
323
-1
-0.3% -$84 ﹤0.01% 969
2016
Q2
$26K Buy
324
+112
+53% +$8.53K ﹤0.01% 912
2016
Q1
$15K Sell
212
-292
-58% -$19.6K ﹤0.01% 1059
2015
Q4
$36K Buy
+504
New +$33.9K 0.01% 801

Other funds holding DGX

Wealthspire Advisors (Maryland)'s DGX Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Quest Diagnostics (DGX) in Q2 2019, closing a stake of 1,198 shares — an estimated $108K sold.

Wealthspire Advisors (Maryland) first reported a position in DGX in Q4 2015 and held it in 14 quarters. The position peaked at $108K in Q1 2019. 654 funds tracked by Wall St. Rank hold DGX as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Quest Diagnostics position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 1,198 Quest Diagnostics shares in Q2 2019, an estimated $108K.
  • Wealthspire Advisors (Maryland) first reported a position in Quest Diagnostics in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Quest Diagnostics position peaked at $108K in Q1 2019.
  • 654 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.